Evusheld

Evusheld is a new medication consisting of a combination of two monoclonal antibodies. It is used to prevent COVID-19 infection before exposure to the virus.

How does Evusheld work?

Monoclonal antibodies are lab-engineered proteins designed to target specific viruses, such as the coronavirus. Evusheld binds to the spike protein on the surface of the coronavirus. This binding blocks the virus from entering human cells, thereby protecting the body from infection.